Collegium Pharmaceutical Inc (COLL) Insider Trading
- $4,316,951.25
- $56,408,948.35
- Jan. 16, 2024
- Michael Thomas Heffernan
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 16, 2024 | EVP | 23,560 | $32.28 | Sell | $760,516.80 | |
| Dec. 21, 2023 | CEO | 4,357 | $30.38 | Sell | $132,365.66 | |
| Dec. 19, 2023 | CEO | 14,516 | $30.03 | Sell | $435,915.48 | |
| Nov. 27, 2023 | EVP | 25,600 | $25.78 | Sell | $659,968.00 | |
| June 26, 2023 | EVP | 17,984 | $21.72 | Sell | $390,612.48 | |
| June 1, 2023 | CEO | 31,272 | $22.09 | Sell | $690,798.48 | |
| May 30, 2023 | CEO | 31,271 | $21.90 | Sell | $684,834.90 | |
| March 15, 2023 | CFO | 31,640 | $23.77 | Sell | $752,082.80 | |
| March 1, 2023 | EVP | 13,324 | $26.70 | Sell | $355,750.80 | |
| Feb. 13, 2023 | EVP | 21,811 | $26.88 | Sell | $586,279.68 | |
| Feb. 13, 2023 | CEO | 11,250 | $26.88 | Sell | $302,400.00 | |
| Jan. 9, 2023 | EVP | 17,834 | $27.39 | Sell | $488,473.26 | |
| Dec. 27, 2022 | CEO | 2,204 | $23.75 | Sell | $52,345.00 | |
| Dec. 27, 2022 | Director | 19,815 | $23.73 | Sell | $470,209.95 | |
| Dec. 23, 2022 | CEO | 147 | $23.00 | Sell | $3,381.00 | |
| Dec. 22, 2022 | Director | 237 | $23.00 | Sell | $5,451.00 | |
| Dec. 21, 2022 | CEO | 7,333 | $23.11 | Sell | $169,465.63 | |
| Dec. 20, 2022 | Director | 33,758 | $23.08 | Sell | $779,134.64 | |
| Dec. 19, 2022 | CEO | 1,134 | $23.01 | Sell | $26,093.34 | |
| Dec. 12, 2022 | Director | 27,920 | $22.01 | Sell | $614,519.20 | |
| Dec. 1, 2022 | CEO | 76,653 | $22.47 | Sell | $1,722,392.91 | |
| Nov. 28, 2022 | CEO | 43 | $22.00 | Sell | $946.00 | |
| Nov. 22, 2022 | CEO | 65 | $22.00 | Sell | $1,430.00 | |
| Nov. 18, 2022 | CEO | 1,989 | $22.02 | Sell | $43,797.78 | |
| Oct. 4, 2022 | CFO | 4,350 | $17.35 | Sell | $75,472.50 | |
| Sept. 15, 2022 | EVP | 38,589 | $18.07 | Sell | $697,303.23 | |
| Aug. 11, 2022 | EVP | 300 | $20.01 | Sell | $6,003.00 | |
| Feb. 18, 2022 | EVP | 10,559 | $21.61 | Sell | $228,179.99 | |
| Dec. 15, 2021 | EVP | 5,693 | $18.33 | Sell | $104,352.69 | |
| May 10, 2021 | EVP | 7,000 | $22.77 | Sell | $159,390.00 | |
| March 15, 2021 | Director | 50,075 | $25.30 | Sell | $1,266,897.50 | |
| March 1, 2021 | CEO | 64,768 | $22.67 | Sell | $1,468,290.56 | |
| March 1, 2021 | Insider | 6,011 | $23.36 | Sell | $140,416.96 | |
| Jan. 20, 2021 | EVP | 6,081 | $24.45 | Sell | $148,680.45 | |
| Jan. 19, 2021 | Insider | 3,324 | $23.00 | Sell | $76,452.00 | |
| Jan. 15, 2021 | EVP | 1,322 | $22.89 | Sell | $30,260.58 | |
| Jan. 12, 2021 | Insider | 7,500 | $21.00 | Sell | $157,500.00 | |
| Jan. 7, 2021 | CTO | 16,042 | $22.00 | Sell | $352,924.00 | |
| Dec. 3, 2020 | CTO | 5,967 | $19.24 | Sell | $114,805.08 | |
| Oct. 15, 2020 | EVP | 7,060 | $20.82 | Sell | $146,989.20 | |
| July 13, 2020 | EVP | 1,429 | $17.01 | Sell | $24,307.29 | |
| June 1, 2020 | CEO | 70,676 | $21.53 | Sell | $1,521,654.28 | |
| May 13, 2020 | Director | 19,254 | $21.63 | Sell | $416,464.02 | |
| May 13, 2020 | CTO | 7,989 | $21.67 | Sell | $173,121.63 | |
| May 13, 2020 | EVP | 4,434 | $22.61 | Sell | $100,252.74 | |
| Jan. 21, 2020 | Director | 295,287 | $21.93 | Sell | $6,475,643.91 | |
| Jan. 14, 2020 | EVP | 1,321 | $23.87 | Sell | $31,532.27 | |
| Nov. 8, 2019 | Director | 25,000 | $19.33 | Sell | $483,250.00 | |
| Nov. 7, 2019 | CEO | 64,821 | $18.77 | Sell | $1,216,690.17 | |
| Aug. 29, 2019 | Director | 22,106 | $11.65 | Sell | $257,534.90 |
Insiders are both buying and selling Collegium Pharmaceutical Inc stock.
The insider traders at Collegium Pharmaceutical Inc are: Michael Thomas Heffernan, Joseph Ciaffoni, Alison B Fleming, Scott Dreyer, Shirley R Kuhlmann, David Hirsch, Longitude Capital Partners, Ll, Paul Brannelly, Colleen Tupper, John Gordon Freund, and John A Fallon
The most active insider trader at Collegium Pharmaceutical Inc is Michael Thomas Heffernan with 22 trades.
Longitude Capital Partners, Ll has sold the most Collegium Pharmaceutical Inc stock with a total value of $34,680,000.00.
Longitude Capital Partners, Ll has bought the most Collegium Pharmaceutical Inc stock with a total value of $4,800,000.00.
The most recent insider trade for Collegium Pharmaceutical Inc was on Jan. 16, 2024.
The single biggest insider buy for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $2,400,000.00 on May 12, 2015.
The single biggest insider sell for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $17,340,000.00 on Dec. 8, 2017.